iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2023.01.005
Yibulayin Aini , Tiemin Jiang , Hao Wen
{"title":"Feasibility of surgical application of the ligamentum teres hepatis: a review","authors":"Yibulayin Aini , Tiemin Jiang , Hao Wen","doi":"10.1016/j.iliver.2023.01.005","DOIUrl":"https://doi.org/10.1016/j.iliver.2023.01.005","url":null,"abstract":"<div><p>Ligamentum teres hepatis (LTH), a normal anatomical tissue in the liver, is frequently observed during abdominal surgery. Its unique positional and structural characteristics give it a wide range of potential clinical applications, including but not limited to repairing peptic perforation, preventing hemorrhage, treating hiatal hernia, and strengthening the biliary/pancreatic intestine anastomosis to prevent biliary and pancreatic leak. The current review summarizes kinds of methods of using LTH in abdominal surgery, especially some new clinical applications in recent years, involving various organs and fields. At the same time, domestic and foreign literature and research in the past five years are cited to demonstrate the feasibility of these applications. This review may guide surgeons to think and explore more new applications of LTH in all surgery fields.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 50-55"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49717058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2023.01.001
Semra Bulbuloglu , Pınar Harmanci , Fatma Eti Aslan
{"title":"Investigation of perceived stress and psychological well-being in liver recipients having immunosuppressive therapy","authors":"Semra Bulbuloglu , Pınar Harmanci , Fatma Eti Aslan","doi":"10.1016/j.iliver.2023.01.001","DOIUrl":"https://doi.org/10.1016/j.iliver.2023.01.001","url":null,"abstract":"<div><h3>Background and aims</h3><p>In this study, the relationship between perceived stress and psychological well-being was analyzed in liver transplant recipients having immunosuppressive therapy.</p></div><div><h3>Methods</h3><p>This study was performed as descriptive research with 134 patients who had liver transplantation at the organ transplantation institute of a training and research hospital (<em>n</em> = 134). The Perceived Stress Scale and the Psychological Well-Being Scale were used for the data collection. The research data were analyzed by using the Statistical Package for Social Science 25.0.</p></div><div><h3>Results</h3><p>Of all participant liver transplant recipients, 22.4% were aged 18–27 years and 48–57 years and 80.6% were males. Besides, the participant liver transplant recipients used immunosuppressive drugs such as prednisolone (92.53%), tacrolimus (61.9%), and mycophenolate mofetil (52.98%). It was found that there was a statistically significant relationship between psychological well-being and perceived stress.</p></div><div><h3>Conclusion</h3><p>In this study, it was discerned that perceived stress affected psychological well-being negatively. It is of importance to realize the stress experienced by liver transplant recipients and enhance their psychological well-being. In the process following transplant surgery, the liver transplant recipients should be carefully followed and efforts to improve patient outcomes should be made.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 10-15"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49717414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2023.01.002
Ajay K. Yadav , Teja Naveen Sata , Daksh Verma , Amrendra K. Sah , Amit K. Mishra , Mrinalini , Md. Musa Hossain , Kishor Pant , Senthil K. Venugopal
{"title":"Free fatty acid-induced miR-22 inhibits gluconeogenesis via SIRT-1-mediated PGC-1α expression in nonalcoholic fatty liver disease","authors":"Ajay K. Yadav , Teja Naveen Sata , Daksh Verma , Amrendra K. Sah , Amit K. Mishra , Mrinalini , Md. Musa Hossain , Kishor Pant , Senthil K. Venugopal","doi":"10.1016/j.iliver.2023.01.002","DOIUrl":"https://doi.org/10.1016/j.iliver.2023.01.002","url":null,"abstract":"<div><h3>Background and aims</h3><p>Free fatty acids (FFAs) are one of the important regulators of the progression of nonalcoholic fatty liver disease. The FFAs are shown to modulate the metabolic status of the liver by modulating several cellular pathways in hepatocytes. Here, we elucidated the role of miR-22 in modulating FFAs-mediated gluconeogenesis.</p></div><div><h3>Methods</h3><p>Huh7 and WRL68 cells were transfected with nonspecific miRNA, miR-22 premiRs or anti-miR-22 oligos followed by incubation with palmitic acid, oleic acid, and linoleic acid (300 μM each) for 48 and 72 h after transfection. The expression of miR-22 was performed using real-time polymerase chain reaction and Western blots were performed for SIRT-1, PGC-1α, PEPCK, and glucose-6-phosphatase. Three groups of C57BL/6 mice (6 mice per group) were fed with standard diet, choline sufficient <span>l</span>-amino acid defined diet or choline-deficient <span>l</span>-amino acid defined (CDAA) diet for 6, 18, 32, or 54 weeks. Triglycerides content was measured in the serum. Expression of miR-22 and the protein expression of gluconeogenic enzymes were analyzed in the tissue samples.</p></div><div><h3>Results</h3><p>Incubation of miR-22-transfected cells with FFAs inhibited the expression of SIRT-1, PGC-1α, PEPCK, and glucose-6-phosphatase, while miR-22 expression was increased. These changes were reversed when the cells were transfected with anti-miR-22 oligos. CDAA-fed mice showed the significant increase in triglycerides content and miR-22 expression, while there was an inhibition of SIRT-1, PGC-1α, PEPCK, and glucose-6-phosphatase expression in CDAA-fed mice.</p></div><div><h3>Conclusions</h3><p>These data confirm that FFAs inhibited gluconeogenesis via miR-22-mediated inhibition of SIRT-1, which in turn inhibited PGC-1α in hepatic cells.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 1-9"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49717221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2022.12.001
Nourhan Badwei
{"title":"Hepatocellular Carcinoma Gene Expression: The New Era, Where It goes?","authors":"Nourhan Badwei","doi":"10.1016/j.iliver.2022.12.001","DOIUrl":"https://doi.org/10.1016/j.iliver.2022.12.001","url":null,"abstract":"<div><p>Hepatocellular carcinoma is known to be a common primary liver malignancy and a serious leading cause of cancer-related mortality globally. Hence, ongoing recent advances in the genetic field regarding hepatocellular carcinoma paid researchers great attention to identifying various biomarkers to act as diagnostic and prognostic tools for the early detection of hepatocellular carcinoma and also developing targeted therapeutic agents that are indicated and available for advanced stages of hepatocellular carcinomas, however, their antitumor efficacy remains limited and under investigations. Therefore, our review summarized the genetic studies of liver cancer focusing on the somatic mutations, copy number variations, and epigenetic modifications that represent early alterations and oncodrivers in hepatocarcinogenesis, Moreover, the identification of genetic signatures and proteomic targets through hepatocellular carcinoma-related genome-wide screening, to show the ongoing clinical application of such analysis to facilitate diagnosis, prognosis and management of patients with hepatocellular carcinoma for a better outcome.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 36-40"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49735243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Application of biological big data and radiomics in hepatocellular carcinoma","authors":"Guoxu Fang , Jianhui Fan , Zongren Ding , Yongyi Zeng","doi":"10.1016/j.iliver.2023.01.003","DOIUrl":"https://doi.org/10.1016/j.iliver.2023.01.003","url":null,"abstract":"<div><p>Hepatocellular carcinoma (HCC), one of the most common gastrointestinal cancers, has been considered a worldwide threat due to its high incidence and poor prognosis. In recent years, with the continuous emergence and promotion of new sequencing technologies in omics, genomics, transcriptomics, proteomics, and liquid biopsy are used to assess HCC heterogeneity from different perspectives and become a hotspot in the field of tumor precision medicine. In addition, with the continuous improvement of machine learning algorithms and deep learning algorithms, radiomics has made great progress in the field of ultrasound, CT and MRI for HCC. This article mainly reviews the research progress of biological big data and radiomics in HCC, and it provides new methods and ideas for the diagnosis, prognosis, and therapy of HCC.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 41-49"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49717347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2023.01.004
Jianping Song , Jingxian Sun , Shuhong Jing , Tingxiao Zhang , Jianlei Wang , Yanfeng Liu
{"title":"A high level of secreted phosphoprotein 1 is associated with macrophage infiltration and poor prognosis in hepatocellular carcinoma","authors":"Jianping Song , Jingxian Sun , Shuhong Jing , Tingxiao Zhang , Jianlei Wang , Yanfeng Liu","doi":"10.1016/j.iliver.2023.01.004","DOIUrl":"https://doi.org/10.1016/j.iliver.2023.01.004","url":null,"abstract":"<div><h3>Background and aims</h3><p>Secreted phosphoprotein 1 (<em>SPP1</em>) functions in several physiological processes. The role of SPP1 expression in the prognosis and tumor immunity of hepatocellular carcinoma (HCC) is unknown. The aim of this study was to investigate the expression pattern of SPP1 in HCC and its correlation with prognosis and tumor immunity.</p></div><div><h3>Methods</h3><p>Clinical and gene expression data of The Cancer Genome Atlas-liver hepatocellular carcinoma (LIHC) cohort and 11 other HCC datasets were collected. The Kaplan–Meier method and Cox regression analysis were used to analyze the prognostic value of <em>SPP1</em>. The DESeq2 package in R was used to analyze <em>SPP1</em>-related genes. Gene Ontology analysis and gene set enrichment analysis were used to determine the biological function of <em>SPP1</em> in HCC. The single sample Gene Set Enrichment Analysis (ssGSEA) method was used to analyze the immune infiltrates of HCC. Illumina human methylation 450 data and level 3 HTSeq-FPKM data from The Cancer Genome Atlas-LIHC were used to analyze the effects of DNA methylation level on <em>SPP1</em> expression.</p></div><div><h3>Results</h3><p><em>SPP1</em> was overexpressed in HCC and correlated with T stage, histological grade, adjacent hepatic tissue inflammation, and vascular invasion in HCC. The analysis of survival rates indicated that high <em>SPP1</em> levels were associated with poor overall survival in HCC. Functional analysis showed that <em>SPP1</em> is related to tumor immunity, especially macrophage infiltration. Aberrant demethylation of the promoter region is one of the mechanisms underlying the increase of <em>SPP1</em> in HCC.</p></div><div><h3>Conclusion</h3><p>Our results indicate that <em>SPP1</em> is an independent prognostic factor for HCC and is correlated with the clinical features and macrophage infiltration in HCC.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 26-35"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49717370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2023.03.001
Pengpeng Zhang, Tianyin Wang, Hong Liu, X. She, Ke Chen, Yu-jun Zhao, Y. Ming
{"title":"Acute rejection was observed in a combination therapy of CTLA-4 and PD-1 inhibitors before liver transplantation: A case report and literature review","authors":"Pengpeng Zhang, Tianyin Wang, Hong Liu, X. She, Ke Chen, Yu-jun Zhao, Y. Ming","doi":"10.1016/j.iliver.2023.03.001","DOIUrl":"https://doi.org/10.1016/j.iliver.2023.03.001","url":null,"abstract":"","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86278615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2022.12.002
Hao Chi , Dapeng Chen , Yuliang Zhang , Zilin Cui , Yi Bai , Yamin Zhang
{"title":"Single-cell transcriptome analysis reveals a cancer-associated fibroblast marker gene signature in hepatocellular carcinoma that predicts prognosis","authors":"Hao Chi , Dapeng Chen , Yuliang Zhang , Zilin Cui , Yi Bai , Yamin Zhang","doi":"10.1016/j.iliver.2022.12.002","DOIUrl":"https://doi.org/10.1016/j.iliver.2022.12.002","url":null,"abstract":"<div><h3>Background and aims</h3><p>Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death. Multi-pathway combination therapy is used to treat HCC, and immunotherapy is also a routine part of treatment. As a major component of the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) actively participate in cancer progression through complex functions. However, because CAFs dynamically change during cancer development, most of the current treatment strategies targeting CAFs fail. We created a prognostic CAF marker gene signature (CAFMGS) to investigate the utility of CAFs as a prognostic factor and therapeutic target.</p></div><div><h3>Methods</h3><p>Gene Expression Omnibus (GEO) single-cell RNA sequencing (Sc-RNA-seq) data were analyzed to identify CAF marker genes in HCC. The Cancer Genome Atlas (TCGA) database was used as a training cohort to construct the CAFMGS model and the International Cancer Genome Consortium (ICGC) dataset was used to validate the CAFMGS.</p></div><div><h3>Results</h3><p>Marker genes in the CAFMGS model were (0.0001-<em>SPP1</em>), (0.0084-<em>VCX3A</em>), (0.0015-<em>HMGA1</em>), (0.0082-<em>PLOD2</em>), and (0.0075-<em>CACYBP</em>). The CAFMGS_score was separated into high-risk and low-risk groups based on the median of the patients’ OS. Univariate and multivariate analyses confirmed that CAFMGS_score was an independent prognostic factor in the training group. CAFMGS_score was a more accurate prognostic indicator compared with clinicopathological score and tumor mutational burden score.</p></div><div><h3>Conclusion</h3><p>CAFMGS offers a fresh perspective on stromal cell marker genes in HCC prognosis and expands our knowledge of CAF heterogeneity and functional diversity, perhaps paving the way for CAF-targeted immunotherapy in HCC patients.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 16-25"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49717179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2023.02.002
Yingjie Tian , Minghao Liu , Yu Sun , Saiji Fu
{"title":"When liver disease diagnosis encounters deep learning: Analysis, challenges, and prospects","authors":"Yingjie Tian , Minghao Liu , Yu Sun , Saiji Fu","doi":"10.1016/j.iliver.2023.02.002","DOIUrl":"https://doi.org/10.1016/j.iliver.2023.02.002","url":null,"abstract":"<div><p>The liver is the second-largest organ in the human body and is essential for digesting food and removing toxic substances. Viruses, obesity, alcohol use, and other factors can damage the liver and cause liver disease. The diagnosis of liver disease used to depend on the clinical experience of doctors, which made it subjective, difficult, and time-consuming. Deep learning has made breakthroughs in various fields; thus, there is a growing interest in using deep learning methods to solve problems in liver research to assist doctors in diagnosis and treatment. In this paper, we provide an overview of deep learning in liver research using 139 papers from the last 5 years. We also show the relationship between data modalities, liver topics, and applications in liver research using Sankey diagrams and summarize the deep learning methods used for each liver topic, in addition to the relations and trends between these methods. Finally, we discuss the challenges of and expectations for deep learning in liver research.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 73-87"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49734917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLIVERPub Date : 2023-03-01DOI: 10.1016/j.iliver.2023.02.003
Zongxue Li, Ze Zhang, Jing Yu, Xia Du, Pinggui Lei, Zhibing Ruan, Bo Gao
{"title":"Imaging of pregnancy-related liver diseases","authors":"Zongxue Li, Ze Zhang, Jing Yu, Xia Du, Pinggui Lei, Zhibing Ruan, Bo Gao","doi":"10.1016/j.iliver.2023.02.003","DOIUrl":"https://doi.org/10.1016/j.iliver.2023.02.003","url":null,"abstract":"<div><p>Pregnancy-related liver diseases are the most frequent cause of liver dysfunction in pregnancy and pose a real threat to fetal and maternal survival. Although hepatobiliary disorders are uncommon in pregnancy, they may be severe enough to cause risk to both the mother and fetus. There are five different types of liver disease that are unique to pregnancy, including hyperemesis gravidarum, intrahepatic cholestasis of pregnancy, preeclampsia, hemolysis, elevated liver enzyme, and low platelet count syndrome, and acute fatty liver of pregnancy. Ultrasound, computed tomography, and magnetic resonance imaging play important roles in the rapid diagnosis and evaluation of complications. An accurate diagnosis can guide further treatment or the induction of labor to prevent intrauterine fetal death. This review highlights the pathogenesis, clinical features, imaging features, and treatment of pregnancy-related liver diseases with the aim of enhancing awareness of these rare but potentially life-threatening diseases of pregnancy.</p></div>","PeriodicalId":100657,"journal":{"name":"iLIVER","volume":"2 1","pages":"Pages 56-66"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49735106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}